List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 60 studies with search of:   Serbia and Montenegro
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
Conditions: Major Depressive Disorder;   Psychotic Disorders
Intervention: Drug: Mifepristone
2 Terminated Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function
Condition: Congestive Heart Failure
Intervention: Drug: SLV320
3 Completed Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects
Conditions: Atrial Fibrillation;   Atrial Flutter
Intervention: Drug: Tedisamil sesquifumarate
4 Completed An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
Condition: Major Depressive Disorder
Intervention: Drug: Mifepristone
5 Completed Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
Condition: Hypertension
Interventions: Drug: Candesartan cilexetil;   Drug: Hydrochlorothiazide;   Drug: Hydrochlorothiazide
6 Terminated ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases
Condition: Prostate Cancer
Intervention: Drug: Zometa
7 Completed Seroquel in Bipolar Depression Versus Lithium
Conditions: Bipolar Disorder;   Bipolar Depression;   Depression
Intervention: Drug: Quetiapine Fumarate (Seroquel™) drug, mood stabilizer (mood)
8 Recruiting Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy
Condition: Diabetic Neuropathy
Interventions: Drug: Experimental;   Drug: Placebo comparator
9 Active, not recruiting ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation Study
Condition: Diabetes
Interventions: Drug: Placebo;   Drug: AGI-1067;   Drug: AGI-1067
10 Active, not recruiting An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients
Condition: Early Stage Parkinson's Disease
Intervention: Drug: Pardoprunox
11 Completed A Study to Evaluate the Efficacy and Safety of CG5503 in the Treatment of Acute Pain After Abdominal Hysterectomy Compared With Morphine and Placebo
Conditions: Hysterectomy;   Abdominal Pain Assessment;   Visceral Pain
Interventions: Drug: Morphine;   Drug: CG5503 IR;   Drug: CG5503 IR;   Drug: CG5503 IR;   Drug: Placebo
12 Completed Clinical Trial in Patients With Metastatic Colorectal Cancer
Conditions: Colon Cancer;   Rectal Cancer
Intervention: Drug: CoFactor and 5FU
13 Completed Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)
Condition: Thromboembolism
Intervention: Drug: YM150
14 Terminated Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: CP-316,311;   Drug: Placebo;   Drug: Sertraline
15 Recruiting Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Intervention: Drug: CF101
16 Completed A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Certolizumab Pegol
17 Not yet recruiting Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: Rob 803;   Drug: Placebo
18 Completed Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Intervention: Drug: CF101
19 Recruiting PANORAMA Observational Study
Conditions: Arrhythmia;   Cardiac Pacemaker, Artificial;   Defibrillators, Implantable
Intervention: Device: Cardiac Pacemaker, Defibrillator, pacemaker lead
20 Recruiting Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Lurasidone HCl

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services